Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LifeMD, Inc. (LFMD : NSDQ)

• Company Description    LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. Number of Employees: 232

• Price / Volume Information    Yesterday's Closing Price: $2.13 Daily Weekly Monthly 20 Day Moving Average: 141,488 shares Shares Outstanding: 30.80 (millions) Market Capitalization: $65.60 (millions) Beta: 1.01 52 Week High: $16.28 52 Week Low: $1.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.98% -6.76% 12 Week -40.17% -34.63% Year To Date -44.96% -33.44%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 236 FIFTH AVENUE SUITE 400 - NEW YORK,NY 10001 USA ph: 866-351-5907 fax: - cdeutsch@lifemd.com http://www.lifemd.com

• General Corporate Information    Officers Justin Schreiber - Chief Executive Officer and Chairman Marc Benathen - Chief Financial Officer Maria Stan - Principal Accounting Officer Naveen Bhatia - Director Roberto Simon - Director Peer Information LifeMD, Inc. (CHCR) LifeMD, Inc. (ESRX) LifeMD, Inc. (MYDP) LifeMD, Inc. (GBCS) LifeMD, Inc. (LAXAF) LifeMD, Inc. (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 53216B104 SIC: 8011 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 30.80 Most Recent Split Date: 10.00 (0.20:1) Beta: 1.01 Market Capitalization: $65.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.23 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.68 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.41 Price/Cash Flow: - Price / Sales: 0.63 EPS Growth vs. Year Ago Period: 34.21% vs. Previous Quarter: 13.79% Sales Growth vs. Year Ago Period: 59.59% vs. Previous Quarter: 5.93% ROE 03/31/22 - -2,115.32 12/31/21 - - 09/30/21 - - ROA 03/31/22 - -107.59 12/31/21 - -148.19 09/30/21 - -356.55 Current Ratio 03/31/22 - 1.15 12/31/21 - 1.97 09/30/21 - 0.71 Quick Ratio 03/31/22 - 1.11 12/31/21 - 1.90 09/30/21 - 0.63 Operating Margin 03/31/22 - -36.45 12/31/21 - -43.48 09/30/21 - -82.46 Net Margin 03/31/22 - -60.35 12/31/21 - -65.57 09/30/21 - -95.77 Pre-Tax Margin 03/31/22 - -60.47 12/31/21 - -66.02 09/30/21 - -98.17 Book Value 03/31/22 - 0.39 12/31/21 - 0.71 09/30/21 - -0.61 Inventory Turnover 03/31/22 - 13.23 12/31/21 - 11.09 09/30/21 - 10.85 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - - Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - -

Powered by Zacks Investment Research ©